Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
5
×
biotech
5
×
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
5
×
detroit blog main
detroit top stories
indiana blog main
5
×
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
gene therapy
gilead sciences
biogen
cancer
cancer immunotherapy
fda
glaxosmithkline
immunotherapy
johnson & johnson
multiple myeloma
What
bio
roundup
days
news
abbvie’s
acquisitions
ahead
american
announced
annual
approval
ash
august
biofourmis
biogen’s
biopharmaceutical
biotech
blood
borne
bucks
busy
cancer
cancers
celebrate
ceo
chance
collabs
companies
conference
convo
corner
covid
daniel
day
deal
decisions
devices
diego
drug
drugs
Language
unset
Current search:
biotech
×
novartis
×
" clinical trials "
×
" indiana blog main "
×
abbvie
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More